市場調查報告書
商品編碼
1451721
2024-2032 年按類型、技術(DNA/RNA 定序、基因分型、標記輔助選擇、生物資訊學等)、性狀、應用和區域分類的植物性因組市場報告Plant Genomics Market Report by Type, Technology (DNA/RNA Sequencing, Genotyping, Marker-Assisted Selection, Bioinformatics, and Others), Trait, Application, and Region 2024-2032 |
2023年全球植物性因組市場規模達到100億美元。展望未來, IMARC Group預計到2032年市場規模將達到177億美元,2024-2032年複合年成長率(CAGR)為6.33%。
植物性因組學是指用於提高植物質量並旨在確定植物遺傳組成影響植物育種的方式的多種遺傳操作方法。隨著植物性因組學的巨大進步,可以透過防止植物中的黴菌毒素污染並允許作物在極端溫度下生存來改善作物保護。生長較快的植物有助於維持糧食安全並確保市場上有足夠的營養素。植物性因組學也透過開發基因改造作物在減少疾病傳播方面發揮重要作用。分子診斷、分子標記、基因工程、組織培養和有益微生物的開發是用於提高作物品質的基因組學的主要領域。
該市場的主要驅動力是個體中蛋白質缺乏症的盛行率上升,導致對富含蛋白質的植物的需求增加。由於人口的增加,市場對優質水果、蔬菜和穀物的需求不斷增加。此外,為開發多種先進植物性因組學方法而進行的廣泛研究和開發(R&D)活動正在為市場創造積極的前景。除此之外,一些國家的政府機構採取的促進改進植物和作物生長計畫的有利措施也為市場提供了動力。此外,植被覆蓋的廣泛喪失導致採用替代科學方法來改善植被並提高植物生產力。由於基因組學的成本效益和自動化儀器成本的不斷成長,市場對基因組學的偏好轉變進一步推動了自動化儀器的發展。推動市場發展的其他一些因素包括為改善糧食安全而對生物經濟的需求不斷增加、快速城市化、食品和飲料(F&B)行業的大幅成長、素食主義的興起以及對永續發展的日益關注。發展。
The global plant genomics market size reached US$ 10.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.33% during 2024-2032.
Plant genomics refer to numerous genetic manipulation methods that are used to improve plant quality and aim to determine the manner genetic composition of plants affects plant breeding. With numerous advancements in plant genomics, crop protection may be improved by preventing mycotoxin contamination in plants and allowing crops to survive extreme temperatures. The availability of faster growing plants contributes to maintaining food security and ensuring that nutrients are available in the market. Plant genomics also plays an instrumental role in reducing the spread of diseases through the development of genetically modified crops. Molecular diagnostics, molecular markers, genetic engineering, tissue culture, and the development of beneficial microbes are the main areas of genomics that are employed to improve the quality of crops.
The market is majorly driven by the rising prevalence of protein deficiency among individuals, resulting in the augmenting demand for protein-rich plants. The market is experiencing an increase in the demand for fruit, vegetables, and cereals of high quality due to the increasing population. Also, extensive research and development (R&D) activities conducted for developing numerous advanced plant genomics methods are creating a positive outlook for the market. Apart from this, favorable initiatives taken by the government bodies of several countries promoting improved plant and crop growth programs are providing an impetus to the market. Additionally, the widespread loss of vegetative cover is resulting in the implementation of alternative scientific methods to improve vegetation and increase plant productivity. The market is further propelled by the shifting preference toward genomics over automated instruments due to its cost-efficiency and the growing costs of automated instruments. Some of the other factors contributing to the market include the escalating demand for a bio-based economy to improve food security, rapid urbanization, considerable growth in the food and beverage (F&B) industry, the rising trend of veganism and an enhanced focus on sustainable development.
IMARC Group provides an analysis of the key trends in each sub-segment of the global plant genomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, trait and application.
Molecular Engineering
Genetic Engineering
Genome Editing
Others
DNA/RNA Sequencing
Genotyping
Marker-Assisted Selection (MAS)
Bioinformatics
Others
Yield Improvement
Disease Resistance
Herbicide Tolerance
Others
Cereals and Grains
Oilseeds and Pulses
Fruits and Vegetables
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., BGI Genomics, Eurofins Scientific SE, Floragenex Inc., GENEWIZ Inc. (Azenta Inc.), Illumina Inc., Keygene N.V., LC Sciences, Neogen Corporation, Novogene Co. Ltd., NRGene Technologies Ltd., Oxford Nanopore Technologies plc and Qiagen N.V. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.